SpyGlass Pharma (SGP) Financials: Revenue & Earnings
SGP$33.13+2.23 +7.22%
$1.11B
Market Cap
—
P/E
—
Forward P/E
—
Score
SpyGlass Pharma (SGP) Financials: Revenue & Earnings
SGP price $33.13 +2.23 +7.22%
- Ticker
- SGP
- Price
- $33.13
- Change
- +2.23 +7.22%
- Market cap ?
- $1.11B
- Beta ?
- -0.89
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SGP fair value Not meaningful. Price $33.13.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.66 | — | — |
| 2026-08-06 | -0.59 | -0.51 | — | — |
| 2026-05-15 | -0.69 | -0.67 | — | — |
| 2026-03-26 | -5.72 | -0.57 | — | — |
| 2025-12-03 | -0.45 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 53, holders +18 vs prior quarter. Ownership 78.38%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8.02M | 0 | 0.00% | 178.55M |
| NEA MANAGEMENT COMPANY, LLC | 7.39M | 0 | 0.00% | 164.55M |
| SANDS CAPITAL ALTERNATIVES, LLC | 2.50M | 0 | 0.00% | 55.65M |
| SAMSARA BIOCAPITAL, LLC | 2.11M | 0 | 0.00% | 46.97M |
| BLACKROCK, INC. | 711.71K | 566.97K | +391.72% | 15.84M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 674.14K | -30.30K | -4.30% | 15.01M |
| VESTAL POINT CAPITAL, LP | 670.00K | 3.24K | +0.49% | 14.91M |
| JPMORGAN CHASE & CO | 629.74K | 52.63K | +9.12% | 13.63M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 550.00K | 0 | 0.00% | 12.24M |
| MILLENNIUM MANAGEMENT LLC | 507.26K | 38.46K | +8.20% | 11.29M |
| ABERDEEN GROUP PLC | 493.08K | 272.62K | +123.66% | 10.98M |
| VANGUARD CAPITAL MANAGEMENT LLC | 434.42K | -390 | -0.09% | 9.67M |
| GEODE CAPITAL MANAGEMENT, LLC | 277.32K | 150.78K | +119.16% | 6.18M |
| FRANKLIN TEMPLETON INC | 233.41K | -66.59K | -22.20% | 5.20M |
| AFFINITY ASSET ADVISORS, LLC | 131.59K | -118.41K | -47.37% | 2.93M |
| STATE STREET CORP | 117.56K | 100.31K | +581.51% | 2.62M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 85.68K | 26.07K | +43.74% | 1.91M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 85.68K | 85.68K | New | 1.91M |
| NORTHERN TRUST CORP | 82.45K | 61.59K | +295.22% | 1.84M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 75.81K | 72.13K | +1960.11% | 1.69M |
| VANGUARD FIDUCIARY TRUST CO | 68.50K | 8.72K | +14.58% | 1.52M |
| ALYESKA INVESTMENT GROUP, L.P. | 57.00K | 0 | 0.00% | 1.27M |
| TD ASSET MANAGEMENT INC | 47.58K | 0 | 0.00% | 1.06M |
| AMERIPRISE FINANCIAL INC | 45.67K | 1.19K | +2.68% | 1.02M |
| ALPS ADVISORS INC | 33.93K | 33.93K | New | 755.33K |
Earnings and financials
SpyGlass Pharma, Inc. Common Stock (SGP) trades at $33.13, with a market cap of $1.11B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn